Story thread · 2 reports / 2 sources

InduPro raises $77M, begins first human trial of cancer drug

geekwire.com · 2hShare

Seattle biotech InduPro has raised $77 million and dosed its first patient in a Phase 1 trial of an experimental cancer drug, as the company advances its novel approach to targeting tumor cells. Read More

First report: AbCellera, Silence and InduPro all raise significant funding — endpts.com, 2d